Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3

We did a deep dive into the pharmaceutical industry’s 2022Q2/Q3 news, and there’s a ton of exciting updates to share. In this review, we highlight some emerging companies, technologies, and drug discovery modalities we thought drug hunters would find interesting, including:

  • New strategies for covalent protein modification
  • Different methods for screening drug candidates and targets
  • Interesting new approaches with large molecules
  • Recent updates in radiopharmaceuticals

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more:


Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

Join Subscribers from